Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Karthik S, Sharma LP, Narayanaswamy JC. <p>Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives</p>. Neuropsychiatric
Disease and Treatment [Internet]. 2020 abr;Volume 16:1003–13. Available from: http://dx.doi.org/10.2147/NDT.S211703
NEUROBIOLOGIA
Estudios neurobiológicos y
genéticos se han centrado
particularmente en la
serotonina: polimorfismos
en el transportador de
serotonina, estudios de PET
sugieren una reducción en
el receptor 5-HT2A en la
corteza en pacientes sin
tratamiento previo
Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: Neurobiology,
pathophysiology, and treatment. Pharmacology & Therapeutics [Internet]. 2011 dic;132(3):314–32. Available from:
http://dx.doi.org/10.1016/j.pharmthera.2011.09.006
EVIDENCIA DE ROL NEUROTRANSMISION
GLUTAMATERGICA
Modelos de Comportamiento en Animales
Modelo de
Entierro de Aseo obsesivo en
atenuación de
canicas perros
señal
Karthik S, Sharma LP, Narayanaswamy JC. <p>Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives</p>. Neuropsychiatric Disease and
Treatment [Internet]. 2020 abr;Volume 16:1003–13. Available from: http://dx.doi.org/10.2147/NDT.S211703
EVIDENCIA DE ROL NEUROTRANSMISION
GLUTAMATERGICA
Evidencia de Estudios Neurofisiológicos
Estudios en LCR
Estudios de Imagen
Karthik S, Sharma LP, Narayanaswamy JC. <p>Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives</p>. Neuropsychiatric Disease and
Treatment [Internet]. 2020 abr;Volume 16:1003–13. Available from: http://dx.doi.org/10.2147/NDT.S211703
EVIDENCIA DE ROL NEUROTRANSMISION GLUTAMATERGICA
Zhu Y, Fan Q, Han X, Zhang H, Chen J, Wang Z, et al. Decreased thalamic glutamate level in unmedicated adult obsessive–compulsive disorder patients detected by proton
magnetic resonance spectroscopy. Journal of Affective Disorders [Internet]. 2015 jun;178:193–200. Available from: http://dx.doi.org/10.1016/j.jad.2015.03.008
TARGET MOLECULARES DE DIFERENTES
DROGAS GLUTAMATERGICAS
Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment. Pharmacology & Therapeutics
[Internet]. 2011 dic;132(3):314–32. Available from: http://dx.doi.org/10.1016/j.pharmthera.2011.09.006
FÁRMACOS GLUTAMINÉRGICOS
UTILIZADOS EN TOC
Droga Dosis/día Nivel de evidencia Efectos adversos
Memantina 20 mg 2 Cefalea, somnolencia,
confusión
N-Acetylcysteina 2400 mg 2 Nausea, vómitos, rubicundez
Lamotrigina 100mg 2 Rash, SJS
Topiramato 200 mg 2 Cálculos Renales
Riluzole 100mg 2 Nausea, vómitos, fatiga,
elevación de PFH
Glicina 60mg ------- Nausea, sabor desagradable,
constipación
D-cycloserina 125 mg/infusión ------------ Cefalea, somnolencia, vértigo,
temblor, convulsiones
Narayanaswamy J, Sheshachala K. Glutamatergic augmentation strategies in obsessive–compulsive disorder. Indian Journal of Psychiatry [Internet]. 2019;61(7):58. Available from:
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_520_18
TRASTORNO BIPOLAR Y TOC
Kazhungil F, Mohandas E. Management of obsessive-compulsive disorder comorbid with bipolar disorder. Indian Journal of Psychiatry [Internet]. 2016;58(3):259. Available
from: http://dx.doi.org/10.4103/0019-5545.192001
TRASTORNO BIPOLAR Y TOC
Kazhungil F, Mohandas E. Management of obsessive-compulsive disorder comorbid with bipolar disorder. Indian Journal of Psychiatry [Internet]. 2016;58(3):259. Available
from: http://dx.doi.org/10.4103/0019-5545.192001
TRASTORNO BIPOLAR Y TOC
Pallanti S, Grassi G. Pharmacologic treatment of obsessive-compulsive disorder comorbidity. Expert Opinion on Pharmacotherapy [Internet]. 2014 sep 25;15(17):2543–52.
Available from: http://dx.doi.org/10.1517/14656566.2014.964208
TRASTORNO BIPOLAR Y TOC
Pallanti S, Grassi G. Pharmacologic treatment of obsessive-compulsive disorder comorbidity. Expert Opinion on Pharmacotherapy [Internet]. 2014 sep 25;15(17):2543–
52. Available from: http://dx.doi.org/10.1517/14656566.2014.964208